American Vanguard (AVD) AI Stock Analysis

• Market Cap: $128.11M
• Dividend Yield: N/A
• Average Volume (3M): 170.07K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.95
• Revenue Growth: -4.29%
• EPS Growth: -276.74%
• Country: US
• Employees: 845
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): -0.43
• Shares Outstanding: 28,468,140
• 10 Day Avg. Volume: 164,446
• 30 Day Avg. Volume: 170,075
• PEG Ratio: <0.01
• Price to Book (P/B): 0.56
• Price to Sales (P/S): 0.24
• P/FCF Ratio: -34.51
• Enterprise Value/Market Cap: 2.71
• Enterprise Value/Revenue: 0.66
• Enterprise Value/Gross Profit: 2.72
• Enterprise Value/Ebitda: -63.85
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): -0.13
• Revenue Forecast (FY): $536.11M

• Rating: 47 Neutral
• Price Target: $4.50 ▲(0.45% Upside)

American Vanguard's overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. Despite positive developments highlighted in the earnings call, such as improved EBITDA and cost management, the company's financial health remains a significant risk. Technical indicators also suggest bearish momentum, further weighing down the score.

Positive Factors

EBITDA Growth

Significant EBITDA growth indicates improved operational efficiency and cost management, enhancing long-term profitability and competitiveness.

Cost Management

Effective cost management strategies improve margins and free up resources for strategic investments, supporting sustainable growth.

U.S. Crop Business Performance

Strong performance in the U.S. crop segment underscores market leadership and product demand, bolstering revenue stability.

Negative Factors

Rising Debt Levels

Increased leverage can strain financial flexibility and elevate risk, potentially impacting the company's ability to invest in growth.

Declining Cash Flow

Weak cash generation limits the company's ability to fund operations and growth initiatives, posing a risk to financial health.

International Market Challenges

Challenges in international markets may hinder revenue growth and diversification, affecting long-term market expansion.

American Vanguard Business Overview & Revenue Model

Company Description

American Vanguard Corporation (AVD) is a diversified specialty chemical company that focuses on the development and marketing of innovative crop protection products and other agricultural solutions. Operating primarily in the agricultural sector, the company offers a range of products, including insecticides, herbicides, fungicides, and soil fumigants. AVD is dedicated to enhancing agricultural productivity and sustainability through its advanced chemical formulations and technologies.

How the Company Makes Money

American Vanguard generates revenue through the sale of its agricultural products, which are sold to distributors and directly to farmers. The company’s primary revenue streams include the sale of crop protection chemicals, specialty fertilizers, and other related products. Additionally, AVD often engages in partnerships and collaborations with other agricultural companies and research institutions to develop new products and technologies, which can enhance its market reach and product offerings. The company's focus on innovation and sustainability also positions it well in a market increasingly driven by environmental considerations, potentially leading to additional revenue opportunities through the development of eco-friendly products.

American Vanguard Financial Statement Overview

Summary

American Vanguard faces significant financial challenges. Despite positive revenue growth, profitability has deteriorated, and leverage has increased, raising concerns about financial stability. Cash flow generation is weak, with negative growth and low cash conversion ratios. The company needs to address operational inefficiencies and manage debt levels to improve its financial health.

Income Statement

American Vanguard's income statement shows a concerning trend with declining profitability. The TTM data reveals a negative net profit margin of -23.72% and a negative EBIT margin of -19.18%, indicating operational challenges. Revenue growth is positive at 19% TTM, but the company has struggled to convert this into profit, as evidenced by the negative EBITDA margin of -16.06%. Historical data shows a decline from positive margins in 2022, highlighting a significant downturn in financial performance.

Balance Sheet

The balance sheet reflects a moderate level of financial stability. The debt-to-equity ratio has increased to 0.90 TTM from 0.21 in 2022, indicating rising leverage. Return on equity has turned negative at -49.15% TTM, a sharp decline from positive returns in previous years, suggesting inefficiencies in generating shareholder value. The equity ratio remains stable, but the increased debt levels pose a potential risk.

Cash Flow

Cash flow analysis shows significant challenges, with free cash flow growth at -83.67% TTM, indicating a substantial decline in cash generation. The operating cash flow to net income ratio is low at 0.10, reflecting weak cash conversion efficiency. Although the free cash flow to net income ratio is relatively high at 0.89, the overall cash flow position is concerning due to negative growth and low operating cash flow coverage.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	530.07M	547.31M	579.37M	609.62M	557.68M	458.70M
Gross Profit	127.80M	120.32M	179.16M	241.35M	170.72M	172.59M
EBITDA	-5.44M	-9.43M	44.72M	62.79M	57.00M	43.29M
Net Income	-112.10M	-126.34M	7.52M	27.40M	18.59M	15.24M
Balance Sheet
Total Assets	655.01M	636.72M	767.55M	726.31M	694.16M	680.29M
Cash, Cash Equivalents and Short-Term Investments	16.80M	12.51M	11.42M	20.33M	16.29M	15.92M
Total Debt	200.59M	167.81M	162.09M	76.25M	78.08M	119.81M
Total Liabilities	434.02M	403.61M	397.54M	356.33M	321.42M	319.56M
Stockholders Equity	220.99M	233.11M	370.01M	369.98M	372.74M	360.74M
Cash Flow
Free Cash Flow	2.91M	-3.77M	-70.81M	42.55M	76.32M	75.06M
Operating Cash Flow	6.63M	3.92M	-58.75M	57.10M	86.36M	90.32M
Investing Cash Flow	-2.28M	-6.62M	-17.02M	-14.47M	-20.04M	-35.80M
Financing Cash Flow	-222.00K	4.54M	66.74M	-38.26M	-65.87M	-44.44M

American Vanguard Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 4.48
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVD, the sentiment is Negative. The current price of 4.48 is below the 20-day moving average (MA) of 4.72, below the 50-day MA of 5.01, and below the 200-day MA of 4.62, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 46.13 is Neutral, neither overbought nor oversold. The STOCH value of 68.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVD.

American Vanguard Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UAN	74 Outperform	$1.01B	7.93	42.00%	12.54%	16.52%	141.96%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
IPI	53 Neutral	$343.46M	―	-33.37%	―	8.88%	-349.99%
BIOX	49 Neutral	$111.00M	-2.16	-20.52%	―	-27.90%	-4194.67%
AVD	47 Neutral	$128.11M	―	-40.84%	―	-4.29%	-276.74%
LVRO	44 Neutral	$110.38M	―	―	―	―	―
BHST	41 Neutral	$143.18M	―	-200.22%	―	45.88%	43.12%

American Vanguard Corporate Events

American Vanguard Reports Q3 2025 Financial Improvement

American Vanguard reported a substantial improvement in its financial performance for the third quarter of 2025, with an adjusted EBITDA of $8.2 million compared to $1.8 million in the same period last year. The company attributes these results to greater manufacturing efficiency, reduced operational expenses, and lower net trade working capital, despite a challenging agricultural environment. The company maintained its full-year 2025 EBITDA guidance of $40 million to $44 million and plans to focus on its business improvement plan, which has already shown positive results. Additionally, American Vanguard intends to rename its non-crop business to the Specialty business to better align with industry peers and highlight its advanced technologies.

The most recent analyst rating on (AVD) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on American Vanguard stock, see the AVD Stock Forecast page.

American Vanguard Reports Improved Q3 2025 Results

American Vanguard Corporation is a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management, and commercial pest control.

American Vanguard’s Earnings Call Highlights Robust Growth

American Vanguard Corporation’s recent earnings call exuded a positive sentiment, highlighting significant financial improvements. The company reported notable gains in EBITDA, gross margins, and effective cost management strategies. Despite facing challenges in international markets and trade tensions with China, American Vanguard’s robust performance in the U.S. crop sector served as a counterbalance to these issues.

American Vanguard Extends Loan Agreement with BMO Bank

On August 18, 2025, American Vanguard‘s subsidiary, AMVAC Chemical Corporation, amended its senior credit facility with a group of commercial lenders led by BMO Bank. The amendment extends the maturity date of the loan agreement to December 31, 2026, and adjusts the borrowing capacity under the revolving credit facility. This extension is seen as a vote of confidence in American Vanguard’s ongoing transformation and improvement, allowing the management to better demonstrate the company’s earnings potential to investors.

The most recent analyst rating on (AVD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on American Vanguard stock, see the AVD Stock Forecast page.